Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.366
https://www.valueinhealthjournal.com/article/S1098-3015(16)31733-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
339
First Page :
A409
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31733-8&doi=10.1016/j.jval.2016.09.366